Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: LVW reports funding from GSK, Pfizer, Orion Pharma and Genentech, outside of the submitted work.
Conflict of interest: LVW reports consultancy for GSK, Galapagos and Boehringer-Ingelheim. RGJ has received grants from Astra Zeneca, Biogen, Galecto, GlaxoSmithKline, Nordic Biosciences, RedX and Pliant and consulting fees from AstraZeneca, Brainomix, Bristol Myers Squibb, Chiesi, Cohbar, Daewoong, GlaxoSmithKline, Veracyte, Resolution Therapeutics, Pliant and personal fees for advisory board participation or speaking fees Boehringer Ingelheim, Chiesi, Galapagos, Vicore, Roche, PatientMPower and AstraZeneca.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received July 6, 2023.
- Accepted September 11, 2023.
- Copyright ©The authors 2023.
This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
